BMY
Bristol-Myers Squibb Co.
NYSE · usd
Bristol-Myers Squibb Co. (BMY) trades at $61.48 (-2.41%) as of 5:11:05 PM EDT on Oct 23, 2026, -0.03% over the past month. Market cap is $128.69B, with 3.0 days to cover in short interest.
Stock performance
How Bristol-Myers Squibb Co. (BMY) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.41%
- 1W
- +2.90%
- 1M
- -0.03%
- YTD
- +13.98%
- 1Y
- +40.27%
- 52-wk range
- $42.52 – $68.64
Key statistics
Today's trading snapshot for BMY: day range, open, previous close, volume and market cap.
- Day range
- $61.31 – $62.84
- Open
- $62.66
- Prev close
- $63.00
- Volume
- 9.76M
- Market cap
- $128.69B
- Shares out
- 2.04B
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Bristol-Myers Squibb Co.: P/E, P/S, P/B, ROE and more.
- P/E
- 13.86
- P/S
- 2.62
- P/B
- 5.77
- P/FCF
- 11.25
- ROE
- 41.6%
- ROA
- 10.6%
- Debt/Equity
- 1.93
- Div yield
- 3.96%
As of Oct 22, 2026
8-K filings
Material corporate events Bristol-Myers Squibb Co. has disclosed to the SEC on Form 8-K.
- Investor communicationsJul 30, 2026
On July 30, 2026, the Company posted on its website at www.bms.com a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the second quarter of 2026 at 8:15 a.m. Eastern time.
- Shareholder meetingsMay 8, 2026
The Annual Meeting of the Company was held on May 5, 2026. Shareholders voted on the matters set forth below. The shareholders elected each of the Company's 11 nominees to serve as directors of the Company until the 2027 Annual Meeting based upon the following votes: [detailed voting results for all 11 directors]
- Investor communicationsApr 30, 2026
On April 30, 2026, the Company posted on its website at www.bms.com a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the first quarter of 2026.
- Investor communicationsFeb 5, 2026
On February 5, 2026, the Company posted on its website at www.bms.com a presentation (the "Bristol Myers Presentation") on certain financial and operating initiatives available for viewing during the Company's conference call and webcast announcing its financial results for the fourth quarter of 2025 and full year of 2025.
- Investor communicationsJan 12, 2026
On January 12, 2026, Bristol-Myers Squibb Company (the "Company") posted an investor presentation to its website at: www.bms.com/investors/events-and-presentations.html. A copy of the investor presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Dividend history and stock splits
Bristol-Myers Squibb Co.'s recent dividend payments and stock splits.
Dividends
- $0.63ex-div Oct 2, 2026
- $0.63ex-div Jul 2, 2026
- $0.63ex-div Apr 2, 2026
- $0.63ex-div Jan 2, 2026
Splits
No recent splits.
BMY short interest
How heavily BMY is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 3.0
- Short interest
- 45.85M
- Avg volume
- 15.25M
As of · reported to FINRA twice monthly.
BMY news
The latest news and headlines about Bristol-Myers Squibb Co. (BMY).
- BMY vs. ABBV: Which Pharma/Biotech Stock Offers More Upside Potential?positiveZacks Investment Research· Oct 23, 2026
- Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?positiveThe Motley Fool· Oct 23, 2026
- Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in RevenuepositiveThe Motley Fool· Oct 22, 2026
- Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 VolatilitypositiveThe Motley Fool· Oct 22, 2026
- Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsightpositiveGlobeNewswire Inc.· Oct 21, 2026
Frequently asked questions
What is the Bristol-Myers Squibb Co. (BMY) stock price today?
Bristol-Myers Squibb Co. (BMY) is trading at $61.48 (-2.41% on the day) as of 5:11:05 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Bristol-Myers Squibb Co.?
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development.
What is the short interest in BMY?
As of Sep 30, 2026, BMY has 45.85M shares short and 3.0 days to cover.
Does Bristol-Myers Squibb Co. (BMY) pay a dividend?
Yes. Bristol-Myers Squibb Co. (BMY)'s most recent dividend was $0.63 per share, with an ex-dividend date of Oct 2, 2026. Full BMY dividend history is available from the Massive API.
What exchange is BMY listed on?
Bristol-Myers Squibb Co. (BMY) trades on NYSE in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of BMY with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BMY analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.